<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05009888</url>
  </required_header>
  <id_info>
    <org_study_id>302225</org_study_id>
    <nct_id>NCT05009888</nct_id>
  </id_info>
  <brief_title>COVID-19 SARS-CoV-2 Antibody Testing Study</brief_title>
  <acronym>SATS</acronym>
  <official_title>COVID-19 SARS-CoV-2 Antibody Testing Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>King's College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>King's College London</source>
  <brief_summary>
    <textblock>
      SATS is a single site feasibility study to assess the practical and psychological feasibility&#xD;
      of using rapid COVID antibody testing of blood obtained from fingertip pin-pricks.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      SATS is a feasibility study conducted at a single site - King's College London and South&#xD;
      London and Maudsley staff working at the Institute of Psychiatry, Psychology and Neuroscience&#xD;
      (IoPPN) at Denmark Hill, London, England. The practical and psychological feasibility of&#xD;
      using rapid COVID antibody testing of blood obtained from fingertip pin-pricks will be&#xD;
      assessed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 2021</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Acceptability of performing antibody testing procedures involving a capillary blood sample collected via finger-prick</measure>
    <time_frame>1 Year</time_frame>
    <description>o Acceptability would be represented by the number of participants who consent to and complete the antibody testing procedure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Test validity of the antibody tests that are performed</measure>
    <time_frame>1 Year</time_frame>
    <description>the number of completed tests that are valid with a positive/negative IgG/IgM result and confirmed with a positive control line compared with invalid test results as confirmed with a negative control result.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>o Representativeness of participants psychological and behavioural reaction to the testing procedure, their test results, and their willingness to be re-tested.</measure>
    <time_frame>1 Year</time_frame>
    <description>Assessed by psychometric testing using visual analogue scales</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>o Representativeness of participants sampled</measure>
    <time_frame>1 Year</time_frame>
    <description>This would be assessed using demographic data collected from participant</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Adult KCL IoPPN Staff</arm_group_label>
    <description>Freely consenting Adult KCL Staff attending King's College London, IoPPN, Denmark Hill site will all have an antibody test on finger prick blood. The antibody test will give a rapid result for the presence of IgG or IgM antibodies to COVID-19</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Staff members based at the Institute of Psychiatry, Psychology and Neuroscience (IoPPN).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  King's College Staff member&#xD;
&#xD;
          -  Aged 18 years or over&#xD;
&#xD;
          -  Able to freely give informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        The participant may not enter the study if ANY of the following apply:&#xD;
&#xD;
          -  known to have an infectious disease including a current SARS-CoV-2 infection.&#xD;
&#xD;
          -  Any significant disease or disorder which, in the opinion of the Investigator, may&#xD;
             either put the participants at risk because of participation in the research study, or&#xD;
             may influence the result of the research study, or the participant's ability to&#xD;
             participate in the research study. Examples of disorders or diseases which would be&#xD;
             excluded include:&#xD;
&#xD;
               -  Medically diagnosed bleeding disorder;&#xD;
&#xD;
               -  Medically diagnosed platelet disorder;&#xD;
&#xD;
               -  Anticoagulant medication.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 12, 2021</study_first_submitted>
  <study_first_submitted_qc>August 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 18, 2021</study_first_posted>
  <last_update_submitted>August 17, 2021</last_update_submitted>
  <last_update_submitted_qc>August 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

